This is a very positive development, and should go a long way to...

This is a very positive development, and should go a long way to counter the overblown concerns about slow enrolment of the FDA trial. What the stock price will do is anyone's guess, but long term, this increases my confidence in SSH.

Ms. Oleson has 400 clinical trials under her belt, so she most assuredly knows what she's doing. And another connection with Medtronic is always a good thing.

Sunshine Heart is making the right moves. Let's hope Mr. Market takes note, sooner rather than later. :)